查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829367

2025年照護現場（POC）血液凝固檢驗全球市場報告

Point-of-Care (POC) Coagulation Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，即時血液凝固檢驗(POC) 市場呈現強勁成長照護現場，市場規模從 2024 年的 11.8 億美元成長至 2025 年的 12.5 億美元，複合年成長率為 5.4%。這段時期的成長歸因於患者需求的不斷成長、就地檢驗的普及趨勢、凝血狀態的高可靠性、自動化以及與電子健康記錄(EHR) 的整合，以及心血管疾病和血液病患病率的不斷上升。

預計未來幾年照護現場(POC)血液凝固檢驗市場規模將穩定成長，到 2029 年將達到 14.7 億美元，複合年成長率為 4.2%。預測期內的成長可歸因於醫療保健領域應用的不斷擴展、居家照護需求的不斷成長、慢性血液病患病率的不斷上升、患者對快速準確檢測的需求以及就地檢驗的興起。預測期內的主要發展趨勢包括技術進步、已開發國家需求旺盛、醫療保健領域應用的不斷擴展、新冠疫情 (COVID-19) 對新興國家的影響以及 POC 診斷的多重化。

照護現場血液凝固檢驗(POC) 是一種診斷方法，無需在中心實驗室，即可在患者或患者附近評估凝血功能。此檢測通常可在幾分鐘內快速獲得結果，使醫護人員能夠及時做出治療決策並最佳化抗凝血治療方案。

POC血液凝固檢驗的主要技術包括光學、機械和電化學。光學技術利用光來實現各種目的，例如資料傳輸、成像和感測。這些檢測透過直接競標和零售等管道分發給醫院、診所和居家醫療機構等最終用戶。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司新報告系列的一部分，該系列提供了照護現場(POC)血液凝固檢驗血液凝固檢驗市場統計數據，包括全球市場規模、區域照護現場、照護現場(POC)血液凝固檢驗市場佔有率的競爭對手、照護現場(POC)血液凝固檢驗的詳細細分市場、市場趨勢和機遇，以及在照護現場(POC)血液凝固檢驗行業取得成功所需的數據。這份照護現場(POC)血液凝固檢驗市場研究報告對該行業的當前和未來情況進行了詳細分析，為您提供所需的一切的完整觀點。

未來五年4.2%的預測成長率比我們先前對該市場的預測略有下降，下降了0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會透過對主要來自瑞士和韓國的凝血活酶試劑和壓電血凝檢測感測器徵收關稅直接影響美國，從而提高快速血凝評估的成本。此外，由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

由於心血管疾病 (CVD) 盛行率的不斷上升，預計照護現場(POC)血液凝固檢驗市場將會成長。 CVD 包括影響心臟和血管的各種疾病，例如心臟疾病和腦血管疾病。 POC血液凝固檢驗在 CVD 治療中起著關鍵作用，它提供有關凝血狀態的即時訊息，從而能夠及時干預並降低出血併發症的風險，尤其是在心血管手術後。例如，2023 年 5 月，美國疾病管制與預防中心報告稱，2021 年心臟病將在美國奪走約 69.5 萬人的生命，佔死亡人數的五分之一。心臟疾病是最常見的原因，在 2021 年造成 375,476 人死亡。心血管疾病盛行率的不斷上升是支持 POC血液凝固檢驗市場成長的關鍵因素。

照護現場(POC)血液凝固檢驗市場由提供血液凝固檢驗服務、現場止血檢測、照護現場服務和快速凝血分析的營業單位所獲得的收益組成。市場價值包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。照護現場(POC)血液凝固檢驗市場還包括凝血分析儀、試紙、凝血酶原時間 (PT) 監測儀、D-二聚體檢測設備和照護現場血液凝固檢驗套件的銷售。該市場的價值是“出廠價”，即商品製造商或創造者出售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接出售給最終客戶的商品價值。該市場中的商品價值還包括商品創造者出售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球照護現場（POC）血液凝固檢驗：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球照護現場（POC）血液凝固檢驗市場：成長率分析
  • 全球照護現場（POC）血液凝固檢驗市場表現：規模與成長，2019-2024
  • 全球照護現場（POC）血液凝固檢驗市場預測：規模與成長，2024-2029年，2034年預測
  • 全球照護現場（POC）血液凝固檢驗：總潛在市場（TAM）

第6章 市場細分

  • 全球照護現場（POC）血液凝固檢驗市場：按技術、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 光學技術
  • 機械工業
  • 電化學技術
  • 全球照護現場（POC）血液凝固檢驗市場：依通路、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 直接競標
  • 零售
  • 全球照護現場（POC）血液凝固檢驗市場：依最終用戶、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 居家護理
  • 全球照護現場（POC）血液凝固檢驗市場：按光學技術（類型）細分、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 反射率測量
  • 螢光偵測
  • 比色檢測
  • 全球照護現場（POC）血液凝固檢驗市場：按機器技術（類型）、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 機械振動
  • 超音波檢測
  • 全球照護現場（POC）血液凝固檢驗市場：按電化學技術（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 安培檢測
  • 電位差檢測
  • 電導率檢測

第7章 區域和國家分析

  • 全球照護現場（POC）血液凝固檢驗市場：區域分析、預測與趨勢，2019-2024 年、2024-2029 年、2034 年
  • 全球照護現場（POC）血液凝固檢驗市場：國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 照護現場（POC）血液凝固檢驗市場：競爭格局
  • 照護現場（POC）血液凝固檢驗市場：公司簡介
    • AT&T Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Danaher Corporation
  • Medtronic Plc
  • Koninklijke Philips NV
  • Sysmex Corporation
  • IDEXX Laboratories Inc.
  • Quidel Corporation
  • Bio-Rad Laboratories Inc.
  • Teleflex Incorporated
  • Werfen SA
  • Nihon Kohden Corporation
  • Horiba Ltd.
  • Hycel
  • Nova Biomedical Corporation
  • Haemonetics Corporation
  • Maccura Biotechnology Co. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年照護現場(POC)血液凝固檢驗市場：提供新機會的國家
  • 2029 年照護現場(POC)血液凝固檢驗市場：細分市場帶來新機會
  • 2029 年照護現場(POC)血液凝固檢驗市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r28769u

Point-of-care (POC) coagulation testing is a diagnostic method that evaluates blood clotting function at or near the patient's location, rather than in a centralized lab. It provides rapid results, typically within minutes, enabling healthcare professionals to make timely treatment decisions and optimize anticoagulation therapy.

The main technologies used in POC coagulation testing are optical, mechanical, and electrochemical. Optical technology utilizes light for various applications, including data transfer, imaging, and sensing. These tests are distributed through channels such as direct tenders and retail to end-users such as hospitals, clinics, and home care settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The point-of-care (POC) coagulation testing market research report is one of a series of new reports from The Business Research Company that provides point-of-care (POC) coagulation testing market statistics, including point-of-care (POC) coagulation testing industry global market size, regional shares, competitors with a point-of-care (POC) coagulation testing market share, detailed point-of-care (POC) coagulation testing market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care (POC) coagulation testing industry. This point-of-care (POC) coagulation testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care (poc) coagulation testing market size has grown strongly in recent years. It will grow from $1.18 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to rise in patient demand, growing trend of point-of-care testing, high reliability of coagulation status on pt test, automation and integration with electronic health records (EHRs), rising incidence of cardiovascular diseases and blood disorders.

The point-of-care (poc) coagulation testing market size is expected to see steady growth in the next few years. It will grow to $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to expanding applications in healthcare, rising demand in homecare settings, increased prevalence of chronic blood disorders, patient demand for rapid and accurate testing, rise in point-of-care testing. Major trends in the forecast period include technological advancements, high demand in developed countries, expanding applications in healthcare, COVID-19 impact, multiplexing POC diagnostics.

The forecast of 4.2% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on thromboplastin reagents and piezoelectric clot detection sensors, largely sourced from Switzerland and South Korea, raising expenses for rapid blood clotting assessments.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The point-of-care (POC) coagulation testing market is expected to grow due to the increasing incidence of cardiovascular diseases (CVDs). CVDs encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease and cerebrovascular disease. POC coagulation testing plays a crucial role in CVD treatment by providing real-time information on coagulation status, enabling timely interventions and reducing the risk of bleeding complications, particularly after cardiac surgery. For example, in May 2023, the Centers for Disease Control and Prevention reported that heart disease claimed about 695,000 lives in the United States in 2021, accounting for 1 in 5 deaths. Coronary heart disease, the most common type, caused 375,476 deaths in 2021. This increasing prevalence of cardiovascular diseases is a key driver behind the growth of the POC coagulation testing market.

Major companies in the point-of-care (POC) coagulation testing market are concentrating on strategic collaborations to enhance their competitive position. These collaborations involve formal agreements between two or more parties to work towards specific, mutually beneficial goals. For example, in October 2021, Trivitron Healthcare partnered with Diagon Ltd. and Vanguard Diagnostics to introduce Coagulation Analyzer products. These analyzers offer precise and efficient coagulation testing, with the collaboration aimed at enhancing patient diagnosis and management. The range of analyzers is designed to cater to various healthcare settings, making coagulation testing more accessible.

In December 2023, Roche, a Switzerland-based pharmaceutical company, acquired LumiraDx Ltd. for $350 million. This acquisition enhances Roche's diagnostics portfolio, enabling more patient-centric healthcare through point-of-care solutions that cover the entire patient journey. LumiraDx Ltd., based in the UK, specializes in point-of-care coagulation testing.

Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care (poc) coagulation testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care (POC) coagulation testing market consists of revenues earned by entities by providing coagulation testing services, on-site hemostasis testing, point-of-care diagnostic services, and rapid coagulation analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care (POC) coagulation testing market also includes sales of coagulation analyzers, test strips, prothrombin time (PT) monitors, D-dimer testing devices, and point-of-care coagulation testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-of-Care (POC) Coagulation Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care (poc) coagulation testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care (poc) coagulation testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care (poc) coagulation testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Optical Technology; Mechanical Technology; Electrochemical Technology
  • 2) By Distribution Channel: Direct Tenders; Retail
  • 3) By End-User: Hospitals; Clinics; Home care
  • Subsegments:
  • 1) By Optical Technology: Reflectance Photometry; Fluorescence Detection; Colorimetric Detection
  • 2) By Mechanical Technology: Mechanical Oscillation; Ultrasonic Detection
  • 3) By Electrochemical Technology: Amperometric Detection; Potentiometric Detection; Conductometric Detection
  • Companies Mentioned: AT&T Corporation; Siemens Healthcare GmbH; Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Danaher Corporation; Medtronic Plc; Koninklijke Philips N.V.; Sysmex Corporation; IDEXX Laboratories Inc.; Quidel Corporation; Bio-Rad Laboratories Inc.; Teleflex Incorporated; Werfen SA; Nihon Kohden Corporation; Horiba Ltd.; Hycel; Nova Biomedical Corporation; Haemonetics Corporation; Maccura Biotechnology Co. Ltd.; Helena Laboratories Corporation; Abaxis Inc.; ARKRAY Inc.; Radiometer Medical ApS; HemoSonics LLC; iLine Microsystems SL; Corgenix Medical Corporation; Quotient Limited; Micropoint Bioscience Inc.; Beijing Succeeder Technology Inc.; EKF Diagnostics Holdings plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-of-Care (POC) Coagulation Testing Market Characteristics

3. Point-of-Care (POC) Coagulation Testing Market Trends And Strategies

4. Point-of-Care (POC) Coagulation Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Point-of-Care (POC) Coagulation Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Point-of-Care (POC) Coagulation Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Point-of-Care (POC) Coagulation Testing Market Growth Rate Analysis
  • 5.4. Global Point-of-Care (POC) Coagulation Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Point-of-Care (POC) Coagulation Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Point-of-Care (POC) Coagulation Testing Total Addressable Market (TAM)

6. Point-of-Care (POC) Coagulation Testing Market Segmentation

  • 6.1. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology
  • 6.2. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Tenders
  • Retail
  • 6.3. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Home care
  • 6.4. Global Point-of-Care (POC) Coagulation Testing Market, Sub-Segmentation Of Optical Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reflectance Photometry
  • Fluorescence Detection
  • Colorimetric Detection
  • 6.5. Global Point-of-Care (POC) Coagulation Testing Market, Sub-Segmentation Of Mechanical Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mechanical Oscillation
  • Ultrasonic Detection
  • 6.6. Global Point-of-Care (POC) Coagulation Testing Market, Sub-Segmentation Of Electrochemical Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amperometric Detection
  • Potentiometric Detection
  • Conductometric Detection

7. Point-of-Care (POC) Coagulation Testing Market Regional And Country Analysis

  • 7.1. Global Point-of-Care (POC) Coagulation Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Point-of-Care (POC) Coagulation Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market

  • 8.1. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point-of-Care (POC) Coagulation Testing Market

  • 9.1. China Point-of-Care (POC) Coagulation Testing Market Overview
  • 9.2. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point-of-Care (POC) Coagulation Testing Market

  • 10.1. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point-of-Care (POC) Coagulation Testing Market

  • 11.1. Japan Point-of-Care (POC) Coagulation Testing Market Overview
  • 11.2. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point-of-Care (POC) Coagulation Testing Market

  • 12.1. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point-of-Care (POC) Coagulation Testing Market

  • 13.1. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point-of-Care (POC) Coagulation Testing Market

  • 14.1. South Korea Point-of-Care (POC) Coagulation Testing Market Overview
  • 14.2. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point-of-Care (POC) Coagulation Testing Market

  • 15.1. Western Europe Point-of-Care (POC) Coagulation Testing Market Overview
  • 15.2. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point-of-Care (POC) Coagulation Testing Market

  • 16.1. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point-of-Care (POC) Coagulation Testing Market

  • 17.1. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point-of-Care (POC) Coagulation Testing Market

  • 18.1. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point-of-Care (POC) Coagulation Testing Market

  • 19.1. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point-of-Care (POC) Coagulation Testing Market

  • 20.1. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point-of-Care (POC) Coagulation Testing Market

  • 21.1. Eastern Europe Point-of-Care (POC) Coagulation Testing Market Overview
  • 21.2. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point-of-Care (POC) Coagulation Testing Market

  • 22.1. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point-of-Care (POC) Coagulation Testing Market

  • 23.1. North America Point-of-Care (POC) Coagulation Testing Market Overview
  • 23.2. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point-of-Care (POC) Coagulation Testing Market

  • 24.1. USA Point-of-Care (POC) Coagulation Testing Market Overview
  • 24.2. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point-of-Care (POC) Coagulation Testing Market

  • 25.1. Canada Point-of-Care (POC) Coagulation Testing Market Overview
  • 25.2. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point-of-Care (POC) Coagulation Testing Market

  • 26.1. South America Point-of-Care (POC) Coagulation Testing Market Overview
  • 26.2. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point-of-Care (POC) Coagulation Testing Market

  • 27.1. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point-of-Care (POC) Coagulation Testing Market

  • 28.1. Middle East Point-of-Care (POC) Coagulation Testing Market Overview
  • 28.2. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point-of-Care (POC) Coagulation Testing Market

  • 29.1. Africa Point-of-Care (POC) Coagulation Testing Market Overview
  • 29.2. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape And Company Profiles

  • 30.1. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape
  • 30.2. Point-of-Care (POC) Coagulation Testing Market Company Profiles
    • 30.2.1. AT&T Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Point-of-Care (POC) Coagulation Testing Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. Medtronic Plc
  • 31.3. Koninklijke Philips N.V.
  • 31.4. Sysmex Corporation
  • 31.5. IDEXX Laboratories Inc.
  • 31.6. Quidel Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Teleflex Incorporated
  • 31.9. Werfen SA
  • 31.10. Nihon Kohden Corporation
  • 31.11. Horiba Ltd.
  • 31.12. Hycel
  • 31.13. Nova Biomedical Corporation
  • 31.14. Haemonetics Corporation
  • 31.15. Maccura Biotechnology Co. Ltd.

32. Global Point-of-Care (POC) Coagulation Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point-of-Care (POC) Coagulation Testing Market

34. Recent Developments In The Point-of-Care (POC) Coagulation Testing Market

35. Point-of-Care (POC) Coagulation Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Point-of-Care (POC) Coagulation Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Point-of-Care (POC) Coagulation Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Point-of-Care (POC) Coagulation Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer